Korea’s SK bioscience will receive up to $173.4 million to assess the efficacy of a new COVID-19 vaccine from Institute for Protein Design.
The collaboration will apply machine learning to the design of new protein-based antivirals and vaccines.
We have annual flu vaccines because the influenza virus mutates every year. The antibodies you made for this season's flu many not protect you against next year's flu version That's why many scientists are trying to create a universal flu vac
Scientists at UW Medicine and the NIH have created an experimental flu vaccine that spurs broad immunity in animal trials.
By creating barrel-shaped proteins that embed into lipid membranes, biochemists have expanded the bioengineering toolkit.
When mixed with fluid from a nasal swab or blood sample, these protein sensors emit light within minutes.
Proteins engineered to form honeycomb structures can block uptake of receptors from the surface of cells.
Research program analyzes cerebrospinal fluid molecules to seek diagnostic and progression markers as well as treatment targets.
Preclinical data published in Cell show the nanoparticle vaccine spurs extremely high levels of protective antibodies in animal models.
Dubbed “The Oscars of Science,” Baker’s award recognizes stellar achievements in building protein molecules from scratch to perform vital functions.
